How to buy Global Cord Blood Corporation stock

Global Cord Blood Corporation is a diagnostics & research business based in the US. Global Cord Blood Corporation shares (CO) are listed on the NYSE and all prices are listed in US Dollars. Global Cord Blood Corporation employs 1,260 staff and has a trailing 12-month revenue of around 0.00.

Global Cord Blood Corporation share price

Use our graph to track the performance of CO stocks over time.

Global Cord Blood Corporation shares at a glance

• Key figures

Information last updated 2021-04-30.

52-week range	$2.54 - $4.98
50-day moving average	$4.67
200-day moving average	$4.20
Wall St. target price	$15.00
PE ratio	8.0033
Dividend yield	$0.076 (1.59%)
Earnings per share (TTM)	$0.61

Buy Global Cord Blood Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Global Cord Blood Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Global Cord Blood Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Global Cord Blood Corporation under- or over-valued?

Valuing Global Cord Blood Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Global Cord Blood Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Global Cord Blood Corporation's P/E ratio

Global Cord Blood Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Global Cord Blood Corporation shares trade at around 8x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Global Cord Blood Corporation's EBITDA

Global Cord Blood Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $593.2 million.

The EBITDA is a measure of a Global Cord Blood Corporation's overall financial performance and is widely used to measure a its profitability.

Global Cord Blood Corporation financials

Revenue TTM	$1.2 billion
Operating margin TTM	47.18%
Gross profit TTM	$1 billion
Return on assets TTM	4.6%
Return on equity TTM	12.05%
Profit margin	41.27%
Book value	$35.00
Market capitalisation	$589.5 million

TTM: trailing 12 months

Shorting Global Cord Blood Corporation shares

There are currently 769,731 Global Cord Blood Corporation shares held short by investors – that's known as Global Cord Blood Corporation's "short interest". This figure is 92.4% up from 400,001 last month.

There are a few different ways that this level of interest in shorting Global Cord Blood Corporation shares can be evaluated.

Global Cord Blood Corporation's "short interest ratio" (SIR)

Global Cord Blood Corporation's "short interest ratio" (SIR) is the quantity of Global Cord Blood Corporation shares currently shorted divided by the average quantity of Global Cord Blood Corporation shares traded daily (recently around 157087.95918367). Global Cord Blood Corporation's SIR currently stands at 4.9. In other words for every 100,000 Global Cord Blood Corporation shares traded daily on the market, roughly 4900 shares are currently held short.

However Global Cord Blood Corporation's short interest can also be evaluated against the total number of Global Cord Blood Corporation shares, or, against the total number of tradable Global Cord Blood Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Global Cord Blood Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Global Cord Blood Corporation shares in existence, roughly 10 shares are currently held short) or 0.0222% of the tradable shares (for every 100,000 tradable Global Cord Blood Corporation shares, roughly 22 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Global Cord Blood Corporation.

Find out more about how you can short Global Cord Blood Corporation stock.

Global Cord Blood Corporation share dividends

We're not expecting Global Cord Blood Corporation to pay a dividend over the next 12 months.

Global Cord Blood Corporation share price volatility

Over the last 12 months, Global Cord Blood Corporation's shares have ranged in value from as little as $2.54 up to $4.98. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Global Cord Blood Corporation's is 0.3883. This would suggest that Global Cord Blood Corporation's shares are less volatile than average (for this exchange).

Global Cord Blood Corporation overview

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2020, it had three operating cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. .

Frequently asked questions

What percentage of Global Cord Blood Corporation is owned by insiders or institutions?
Currently 71.426% of Global Cord Blood Corporation shares are held by insiders and 16.937% by institutions. How many people work for Global Cord Blood Corporation?
Latest data suggests 1,260 work at Global Cord Blood Corporation. When does the fiscal year end for Global Cord Blood Corporation?
Global Cord Blood Corporation's fiscal year ends in March. Where is Global Cord Blood Corporation based?
Global Cord Blood Corporation's address is: Bank of China Tower, Central, Hong Kong What is Global Cord Blood Corporation's ISIN number?
Global Cord Blood Corporation's international securities identification number is: KYG393421030 What is Global Cord Blood Corporation's CUSIP number?
Global Cord Blood Corporation's Committee on Uniform Securities Identification Procedures number is: 698659109